Device Structural Heart

Amplatzer Torqvue 45 X 45

Payments companies reported to CMS as associated with Amplatzer Torqvue 45 X 45. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$18Kassociated payments (2023-2025)
78clinicians with associated payments
1company reporting

By year

2023 $9,406
2024 $7,704
2025 $995

Payments reported as associated with Amplatzer Torqvue 45 X 45, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $6,364
Cardiovascular Disease $4,159
Interventional Cardiology $3,629
Vascular & Interventional Radiology $3,000
Nurse Anesthetist, Certified Registered $807
Internal Medicine $38.82

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Amplatzer Torqvue 45 X 45

These are the largest totals companies reported as associated with Amplatzer Torqvue 45 X 45. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Sreekumar Madassery Chicago, IL Vascular & Interventional Radiology $3,000.00
Rajiv Swamy Sanford, NC Interventional Cardiology $1,800.00
Abdul Razaq Adeniyi Savannah, GA Cardiovascular Disease $1,482.36
Jacob Hantla Chandler, AZ Nurse Anesthetist, Certified Registered $806.98
David Newton Savannah, GA Clinical Cardiac Electrophysiology $711.38
Ali Mortazavi Houston, TX Clinical Cardiac Electrophysiology $510.92
Thomas Carrigan Edgewood, KY Clinical Cardiac Electrophysiology $445.57
Byron Colley Birmingham, AL Clinical Cardiac Electrophysiology $444.89
John Seger Houston, TX Clinical Cardiac Electrophysiology $414.75
Sunil Kapur Boston, MA Cardiovascular Disease $371.65

Prescribed Amplatzer Torqvue 45 X 45?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.